Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Diagnosis of exclusion: a case report of probable glatiramer acetate-induced eosinophilic myocarditis.
Review of MR elastography applications and recent developments.
Medicare Part D payments for neurologist-prescribed drugs.
Long-term follow-up of vanishing tumors in the brain: How should a lesion mimicking primary CNS lymphoma be managed?
Progressive multiple sclerosis: The treatment gap.
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Confronting the diagnosis of multiple sclerosis: a qualitative study of patient experiences.
Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse.
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report.
Chronic inflammatory demyelinating polyneuropathy following malignant melanoma.
Mapi Pharma granted United States patent covering glatiramer depot for multiple sclerosis
An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals.
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Optic nerve disease and axon pathophysiology.
Effects of Panax ginseng in Neurodegenerative Diseases.
Ocrelizumab in multiple sclerosis: risks and benefits.
MRI in multiple sclerosis: a review of the current literature.
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: a Phase 1 study.
MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI.
Epidural blood patch in a patient with multiple sclerosis: is it safe?
Biplanar MRI for the assessment of the spinal cord in multiple sclerosis.
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
Pages
« first
‹ previous
…
114
115
116
117
118
119
120
121
122
…
next ›
last »